Six years of progress in the oral biopharmaceutics area - a summary from the IMI OrBiTo project.
暂无分享,去创建一个
H Lennernäs | A Lindahl | E Sjögren | P Zane | P Langguth | A Müllertz | X Pepin | A Rostami-Hodjegan | B Abrahamsson | M McAllister | P Augustijns | J Butler | R Holm | M Berntsson | H. Lennernäs | B. Abrahamsson | A. Müllertz | P. Augustijns | R. Holm | A. Rostami-Hodjegan | P. Langguth | A. Lindahl | E. Sjögren | J. Butler | X. Pepin | M. McAllister | P. Augustijns | P. Zane | J. Butler | M. Berntsson | René Holm
[1] T. Flanagan. Potential for pharmaceutical excipients to impact absorption: A mechanistic review for BCS Class 1 and 3 drugs. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] N. Patel,et al. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug. , 2017, Molecular pharmaceutics.
[3] M. Karlsson,et al. Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans , 2018, CPT: pharmacometrics & systems pharmacology.
[4] C. Reppas,et al. Evaluation of the Impact of Excipients and an Albendazole Salt on Albendazole Concentrations in Upper Small Intestine Using an In Vitro Biorelevant Gastrointestinal Transfer (BioGIT) System. , 2016, Journal of pharmaceutical sciences.
[5] G. Amidon,et al. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms. , 2016, Molecular pharmaceutics.
[6] B. Hens,et al. In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT. , 2016, International journal of pharmaceutics.
[7] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[8] Clive G. Wilson,et al. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[9] P. Langguth,et al. Improvement of trospium-specific absorption models for fasted and fed states in humans. , 2014, Biopharmaceutics & drug disposition.
[10] Filippos Kesisoglou,et al. Current status and future opportunities for incorporation of dissolution data in pbpk modeling for pharmaceutical development and regulatory applications: orbito consortium commentary. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[11] J. Tack,et al. Exploring the link between gastric motility and intragastric drug distribution in man , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] Talia Flanagan,et al. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] R. Schweins,et al. Liposome formation from bile salt-lipid micelles in the digestion and drug delivery model FaSSIF(mod) estimated by combined time-resolved neutron and dynamic light scattering. , 2011, Molecular pharmaceutics.
[14] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] Christos Reppas,et al. In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] J. Tack,et al. Gastric and Duodenal Ethanol Concentrations after Intake of Alcoholic Beverages in Postprandial Conditions. , 2017, Molecular pharmaceutics.
[17] M. Corsetti,et al. Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] J. Tack,et al. The Effect of Sparkling Water on Intraluminal Formulation Behavior and Systemic Drug Performance. , 2017, Journal of pharmaceutical sciences.
[19] Mark McAllister,et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] K Rowland-Yeo,et al. Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine , 2013, CPT: pharmacometrics & systems pharmacology.
[21] H. Lennernäs,et al. Mechanistic modelling of intestinal drug absorption – The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] David J Brayden,et al. Formulation strategies to improve oral peptide delivery. , 2014, Pharmaceutical patent analyst.
[23] B Abrahamsson,et al. Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of solid oral dosage forms during development. , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[25] J. Kühn,et al. Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI. , 2014, Molecular pharmaceutics.
[26] C. Reppas,et al. Two-Stage Single-Compartment Models to Evaluate Dissolution in the Lower Intestine. , 2015, Journal of pharmaceutical sciences.
[27] N. Hellmann,et al. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development. , 2015, Journal of pharmaceutical sciences.
[28] W. Weitschies,et al. In vitro simulation of realistic gastric pressure profiles , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] Erik Sjögren,et al. Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data. , 2015, Molecular pharmaceutics.
[30] Amitava Mitra,et al. Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report , 2019, The AAPS Journal.
[31] Patrick Augustijns,et al. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study. , 2017, Molecular pharmaceutics.
[32] Martin Bergstrand,et al. PBPK models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] David J Brayden,et al. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update , 2019, Pharmaceutics.
[34] Xavier Pepin,et al. IMI – oral biopharmaceutics tools project – evaluation of bottom‐up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] H. Lennernäs,et al. Regional Intestinal Permeability of Three Model Drugs in Human. , 2016, Molecular pharmaceutics.
[36] R. Holm,et al. Evaluating the predictability of the in vitro transfer model and in vivo rat studies as a surrogate to investigate the supersaturation and precipitation behaviour of different Albendazole formulations for humans , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] P. Augustijns,et al. The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration , 2018, The AAPS Journal.
[38] Anna Eidelman,et al. Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets. , 2016, Molecular pharmaceutics.
[39] W. Weitschies,et al. Influence of Postprandial Intragastric Pressures on Drug Release from Gastroretentive Dosage Forms , 2018, AAPS PharmSciTech.
[40] H. Lennernäs,et al. Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs , 2017, Drug development and industrial pharmacy.
[41] R. Havenaar,et al. Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms. , 2016, International journal of pharmaceutics.
[42] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.
[43] C. Reppas,et al. Physiologically Based Absorption Modeling of Salts of Weak Bases Based on Data in Hypochlorhydric and Achlorhydric Biorelevant Media , 2018, AAPS PharmSciTech.
[44] P. Augustijns,et al. An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: Design, implementation, and evaluation. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[45] J. Parojčić,et al. Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] J. Crison,et al. A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] Clive G. Wilson,et al. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[48] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[49] Erik Sjögren,et al. Direct In Vivo Human Intestinal Permeability (Peff ) Determined with Different Clinical Perfusion and Intubation Methods. , 2015, Journal of pharmaceutical sciences.
[50] Clive G. Wilson,et al. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid , 2017, Molecular pharmaceutics.
[51] N. Patel,et al. Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole. , 2017, Journal of pharmaceutical sciences.
[52] Alexander Blanazs,et al. Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model input. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[53] J. Dressman,et al. In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug release. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[54] C. Reppas,et al. Evaluation of Dissolution in the Lower Intestine and Its Impact on the Absorption Process of High Dose Low Solubility Drugs. , 2017, Molecular pharmaceutics.
[55] Leslie Z. Benet,et al. Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements , 2013, The AAPS Journal.
[56] T. Rades,et al. Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates. , 2016, Food & function.
[57] Amitava Mitra,et al. IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[58] Christel A. S. Bergström,et al. Molecular Structuring and Phase Transition of Lipid-Based Formulations upon Water Dispersion: A Coarse-Grained Molecular Dynamics Simulation Approach , 2017, Molecular pharmaceutics.
[59] Philip Hayward,et al. Biopharmaceutics data management system for anonymised data sharing and curation: First application with orbito IMI project , 2017, Comput. Methods Programs Biomed..
[60] Martin Bergstrand,et al. In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status , 2017, Pharmaceutical Research.
[61] Anette Müllertz,et al. In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[62] Clive G. Wilson,et al. Topography of Simulated Intestinal Equilibrium Solubility , 2019, Molecular pharmaceutics.
[63] P. Langguth,et al. Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems. , 2017, Molecular pharmaceutics.
[64] Christel A. S. Bergström,et al. Partitioning into Colloidal Structures of Fasted State Intestinal Fluid Studied by Molecular Dynamics Simulations , 2016, Langmuir : the ACS journal of surfaces and colloids.
[65] H Lennernäs,et al. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[66] Werner Weitschies,et al. The application of the GastroDuo as an in vitro dissolution tool to simulate the gastric emptying of the postprandial stomach. , 2019, Molecular pharmaceutics.
[67] J. Dressman,et al. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[68] J. Tack,et al. Gastric and Duodenal Diclofenac Concentrations in Healthy Volunteers after Intake of the FDA Standard Meal: In Vivo Observations and in Vitro Explorations. , 2019, Molecular pharmaceutics.
[69] Eleni Karatza,et al. Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults , 2015, Pharmaceutical Research.
[70] Jennifer Dressman,et al. Application of a Refined Developability Classification System. , 2019, Journal of pharmaceutical sciences.
[71] Amitava Mitra,et al. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. , 2017, Molecular pharmaceutics.
[72] H. Lennernäs,et al. Regional Intestinal Permeability in Rats: A Comparison of Methods. , 2017, Molecular pharmaceutics.
[73] Thomas Rades,et al. Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs. , 2016, Journal of pharmaceutical sciences.
[74] Amitava Mitra,et al. IMI – Oral biopharmaceutics tools project – Evaluation of bottom‐up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[75] H Lennernäs,et al. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context. , 2017, Molecular pharmaceutics.
[76] N. Patel,et al. Virtual bioequivalence for achlorhydric subjects: The use of PBPK modelling to assess the formulation‐dependent effect of achlorhydria , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[77] P. Augustijns,et al. Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[78] B. Abrahamsson,et al. A Novel Disintegration Tester for Solid Dosage Forms Enabling Adjustable Hydrodynamics. , 2016, Journal of pharmaceutical sciences.
[79] H. Lennernäs,et al. Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[80] G. Amidon,et al. Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chloride. , 2013, Molecular pharmaceutics.
[81] J. Dressman,et al. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[82] P Zane,et al. In vivo Models and Decision Trees for Formulation Development in Early Drug Development: A Review of Current Practices and Recommendations for Biopharmaceutical Development. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[83] M. Karlsson,et al. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions , 2016, Pharmaceutical Research.
[84] H. Lennernäs,et al. Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms. , 2016, Molecular pharmaceutics.
[85] P. Augustijns,et al. Linking the concentrations of itraconazole and 2‐hydroxypropyl‐&bgr;‐cyclodextrin in human intestinal fluids after oral intake of Sporanox® , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[86] J. Tack,et al. Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium. , 2016, Journal of pharmaceutical sciences.
[87] P. Artursson,et al. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[88] T. Vilsbøll,et al. Mechanism‐Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake , 2016, CPT: pharmacometrics & systems pharmacology.
[89] J. Tack,et al. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[90] Tom Fiolka,et al. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[91] B. Abrahamsson,et al. Computational Fluid Dynamics Simulation of Hydrodynamics and Stresses in the PhEur/USP Disintegration Tester Under Fed and Fasted Fluid Characteristics. , 2015, Journal of pharmaceutical sciences.
[92] W. Weitschies,et al. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus. , 2017, Molecular pharmaceutics.
[93] Clive G. Wilson,et al. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[94] H. Lennernäs,et al. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[95] W. Weitschies,et al. Dissolution of mesalazine modified release tablets under standard and bio‐relevant test conditions , 2015, The Journal of pharmacy and pharmacology.
[96] Christel A. S. Bergström,et al. Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds , 2017, Pharmaceutical Research.
[97] Patrick Augustijns,et al. The artificial membrane insert system as predictive tool for formulation performance evaluation. , 2018, International journal of pharmaceutics.
[98] H. Lennernäs,et al. Intestinal absorption-modifying excipients: a current update on preclinical in vivo evaluations. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[99] J. Dressman,et al. Surface Activity Profiling (SAP): A potential means of predicting intestinal membrane permeability. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[100] Jennifer Dressman,et al. A Refined Developability Classification System. , 2018, Journal of pharmaceutical sciences.
[101] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[102] Kung-I Feng,et al. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[103] T. Rades,et al. Development of a Video-Microscopic Tool To Evaluate the Precipitation Kinetics of Poorly Water Soluble Drugs: A Case Study with Tadalafil and HPMC. , 2017, Molecular pharmaceutics.
[104] M. Corsetti,et al. Gastrointestinal behavior of nano- and microsized fenofibrate: In vivo evaluation in man and in vitro simulation by assessment of the permeation potential. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[105] Xavier Pepin,et al. Mechanistic investigation of the negative food effect of modified release zolpidem , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[106] W. Weitschies,et al. Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools. , 2017, Molecular pharmaceutics.
[107] P. Galle,et al. A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[108] J. Tack,et al. Gastrointestinal behavior of itraconazole in humans - Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution. , 2017, International journal of pharmaceutics.
[109] P. Augustijns,et al. Assessment of Passive Intestinal Permeability Using an Artificial Membrane Insert System. , 2018, Journal of pharmaceutical sciences.
[110] Forner Kristin,et al. Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[111] Bart Hens,et al. Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans. , 2015, Journal of pharmaceutical sciences.